Michael Horberg to Anti-Retroviral Agents
This is a "connection" page, showing publications Michael Horberg has written about Anti-Retroviral Agents.
Connection Strength
2.346
-
HIV testing, staging, and evaluation. Infect Dis Clin North Am. 2014 Sep; 28(3):339-53.
Score: 0.462
-
Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy. AIDS Res Hum Retroviruses. 2012 Dec; 28(12):1630-6.
Score: 0.392
-
Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. JAMA. 2023 01 03; 329(1):52-62.
Score: 0.206
-
Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. AIDS Patient Care STDS. 2015 Jul; 29(7):370-8.
Score: 0.121
-
Reply to Monroe and Brown. Clin Infect Dis. 2014 Jun; 58(11):1640-1.
Score: 0.112
-
Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jan; 58(1):1-10.
Score: 0.110
-
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One. 2013; 8(11):e78952.
Score: 0.109
-
Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jan; 58(1):e1-34.
Score: 0.109
-
Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. J Int Assoc Provid AIDS Care. 2013 May-Jun; 12(3):208-16.
Score: 0.105
-
Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):356-62.
Score: 0.104
-
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med. 2012 Sep 04; 157(5):325-35.
Score: 0.101
-
Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009 Sep; 24(9):1065-72.
Score: 0.081
-
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009 Apr 30; 360(18):1815-26.
Score: 0.079
-
Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. Lancet HIV. 2022 03; 9 Suppl 1:S2.
Score: 0.049
-
Clinic-Level Factors Associated With Time to Antiretroviral Initiation and Viral Suppression in a Large, Urban Cohort. Clin Infect Dis. 2020 10 23; 71(7):e151-e158.
Score: 0.044
-
Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data. AIDS Behav. 2020 Jun; 24(6):1784-1792.
Score: 0.043
-
Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):160-6.
Score: 0.028
-
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014 Apr; 58(8):1185-9.
Score: 0.028
-
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013 Feb 01; 62(2):149-63.
Score: 0.026
-
Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010 Jul 17; 24(11):1765-70.
Score: 0.022
-
Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events. Med Care. 2005 Sep; 43(9 Suppl):III63-8.
Score: 0.015